Differential diagnosis of sarcoidosis and tuberculosis using Mycobacterium tuberculosis-specific blood immune signatures 3700

Le résumé fourni par la source

Abstract Description Sarcoidosis is a granulomatous systemic inflammatory disease predominantly affecting the lungs. It shares histopathological, clinical and immune features with tuberculosis (TB). There are currently no diagnostic tests to formally identify sarcoidosis; instead, there is a need to first rule out the presence of other diseases, including TB. Here, we characterized Mycobacterium tuberculosis (Mtb)-specific immune responses in the blood of pulmonary sarcoidosis patients in comparison to TB disease, Mtb-sensitized, and non-sensitized healthy controls using flow cytometry and transcriptomics. We found that sarcoidosis was associated with i) a marked reduction in the frequency of antigen-reactive T cells in response to both Mtb peptides and Mtb lysate, ii) increased frequency of monocytes ex vivo and after in vitro stimulation, and iii) increased expression of monocyte-associated phagocytic genes compared to Mtb-infected and healthy cohorts. A combination of Mtb-specific T cell and monocyte gene or flow cytometry signatures in Mtb-stimulated PBMC could efficiently distinguish sarcoidosis from TB disease with high specificity (90-100%) and sensitivity (89-100%) and, to a lower extent, from Mtb-sensitized and non-sensitized healthy controls (69-91% specificity, and 73-89% sensitivity). These biomarkers offer promising aspects for developing accurate diagnosis tests for the differential diagnosis of sarcoidosis and TB. Topic Categories Translational and Interventional Immunology (TI)

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.